Prospects for reprogramming the immune system in multiple sclerosis

Prospects for reprogramming the immune system in multiple sclerosis

Detalhes bibliográficos
Autor principal:	Waldmann, H
Formato:	Conference item
Publicado em:	2007

Registos relacionados

Reprogramming the immune system.
Por: Waldmann, H
Publicado em: (2008)

Reprogramming the immune system.
Por: Waldmann, H
Publicado em: (2002)

REPROGRAMMING THE IMMUNE-SYSTEM
Por: Waldmann, H, et al.
Publicado em: (1993)

Reprogramming the immune system using antibodies.
Por: Graca, L, et al.
Publicado em: (2006)

Reprogramming the immune system for tolerance with monoclonal antibodies.
Por: Cobbold, S, et al.
Publicado em: (1990)

Reprogramming the immune system towards regulation
Por: Waldmann, H, et al.
Publicado em: (2010)

Reprogramming the immune system: co-receptor blockade as a paradigm for harnessing tolerance mechanisms.
Por: Waldmann, H, et al.
Publicado em: (2008)

Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
Por: Cobbold, S, et al.
Publicado em: (1992)

Astrocytes Undergo Metabolic Reprogramming in the Multiple Sclerosis Animal Model
Por: Sofia Pereira das Neves, et al.
Publicado em: (2023-10-01)

Reprogramming the immune system: a possible therapeutic approach to established autoimmune disease.
Por: Waldmann, H, et al.
Publicado em: (1993)

Effect of puberty on the immune system: Relevance to multiple sclerosis
Por: Carmen C. Ucciferri, et al.
Publicado em: (2022-12-01)

Cortical injury in multiple sclerosis; the role of the immune system
Por: Walker Caroline A, et al.
Publicado em: (2011-12-01)

Immune-mediated genesis of multiple sclerosis
Por: Salvatore Cavallo, MD, Specialist in Medical Genetics
Publicado em: (2020-01-01)

Similarities in the Metabolic Reprogramming of Immune System and Endothelium
Por: Chu-Yik Tang, et al.
Publicado em: (2017-07-01)

THE INVERSION OF HOMEOSTATIC PROPERTIES OF THE IMMUNE SYSTEM IN PATIENTS WITH MULTIPLE SCLEROSIS
Por: I. I. Andreevа, et al.
Publicado em: (2016-06-01)

CAMPATH-IH in multiple sclerosis.
Por: Moreau, T, et al.
Publicado em: (1996)

Prospects of siponimod in secondary progressive multiple sclerosis
Por: Marisa McGinley, et al.
Publicado em: (2018-07-01)

Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma
Por: Shaojie Wu, et al.
Publicado em: (2021-01-01)

The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View
Por: Alessandro Maglione, et al.
Publicado em: (2019-10-01)

Role of innate immune cells in multiple sclerosis
Por: Carolina Prado, et al.
Publicado em: (2025-02-01)

Pulsed immune reconstitution therapy in multiple sclerosis
Por: Per Soelberg Sorensen, et al.
Publicado em: (2019-03-01)

Prospects for the use of curcumin as an additional treatment for multiple sclerosis
Por: V. S. Rogovskii, et al.
Publicado em: (2023-08-01)

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.
Por: Moreau, T, et al.
Publicado em: (1996)

CELLULAR IMMUNITY PARAMETERS IN PATIENTS WITH REMITTING MULTIPLE SCLEROSIS
Por: I. P. Ivanova, et al.
Publicado em: (2021-10-01)

EBV-specific T-cell immunity: relevance for multiple sclerosis
Por: Malina Behrens, et al.
Publicado em: (2024-12-01)

Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
Por: Norma Y. Hernández-Pedro, et al.
Publicado em: (2013-01-01)

Acetate correlates with disability and immune response in multiple sclerosis
Por: Silvia Pérez-Pérez, et al.
Publicado em: (2020-11-01)

Neuro-immune crosstalk in depressive symptoms of multiple sclerosis
Por: Chao Wang, et al.
Publicado em: (2023-02-01)

CD8+ T cells as immune regulators of multiple sclerosis
Por: Sushmita eSinha, et al.
Publicado em: (2015-12-01)

Cerebrospinal fluid cells immune landscape in multiple sclerosis
Por: Zijian Li, et al.
Publicado em: (2021-03-01)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
Por: Kyle K. Payne, et al.
Publicado em: (2012-01-01)

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
Por: Cox, A, et al.
Publicado em: (2005)

Understanding and Modulating Immunity With Cell Reprogramming
Por: Cristiana F. Pires, et al.
Publicado em: (2019-12-01)

The cancer metabolic reprogramming and immune response
Por: Longzheng Xia, et al.
Publicado em: (2021-02-01)

Interferon gene therapy reprograms the leukemia microenvironment inducing protective immunity to multiple tumor antigens
Por: Giulia Escobar, et al.
Publicado em: (2018-07-01)

Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
Por: I. V. Smagina, et al.
Publicado em: (2010-08-01)

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects
Por: Jiwon Oh, et al.
Publicado em: (2014-09-01)

Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica.
Por: Jarius, S, et al.
Publicado em: (2008)

Lipid Metabolism Reprogramming of Immune Cells in Acne: An Update
Por: Wu S, et al.
Publicado em: (2023-09-01)

Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma
Por: Songlei Zhou, et al.
Publicado em: (2023-01-01)